# Favrille

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/favrille

- Industry: Biotechnology
- Headquarters: San Diego, US
- Total disclosed funding: $72M
- Latest round: Series C (Apr 7, 2004)
- Investors on record: 15

## About

Favrille is based in the US and operates as a biopharmaceutical company focused on the development and commercialization of patient-specific immunotherapies for the treatment of cancer and other diseases of the immune system.

## Funding rounds

- Series C, Apr 7, 2004, $44M — Alloy Ventures, Forward Ventures, Sanderling Ventures, William Blair Capital Partners, De Novo Ventures, Oakwood Medical Investors, O-Bank, Needham Capital Partners, Piper Sandler, Lotus Biosciences Ventures, Howard Hughes Medical Institute, AvTech Ventures
- Series B, Oct 20, 2003, $11M — Alloy Ventures, Forward Ventures, Sanderling Ventures, Heller Financial, De Novo Ventures, Gray Ghost Ventures, Lotus Biosciences Ventures
- Series B, Jun 1, 2002, $17M — Alloy Ventures, Forward Ventures, Sanderling Ventures, De Novo Ventures, Indofin Group, Lotus Biosciences Ventures

## Investors

- Alloy Ventures (https://capitalatlas.ai/funds/alloy-ventures) — Series B, Series C
- Forward Ventures (https://capitalatlas.ai/funds/forward-ventures) — Series B, Series C
- Sanderling Ventures (https://capitalatlas.ai/funds/sanderling-ventures) — Series B, Series C
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series B, Series C
- Indofin Group — Series B
- Lotus Biosciences Ventures (https://capitalatlas.ai/funds/lotus-biosciences-ventures) — Series B, Series C
- Heller Financial — Series B
- Gray Ghost Ventures (https://capitalatlas.ai/funds/gray-ghost-ventures) — Series B
- William Blair Capital Partners (https://capitalatlas.ai/funds/william-blair-capital-partners) — Series C
- Oakwood Medical Investors (https://capitalatlas.ai/funds/oakwood-medical-investors) — Series C
- O-Bank (https://capitalatlas.ai/funds/o-bank) — Series C
- Needham Capital Partners (https://capitalatlas.ai/funds/needham-capital-partners) — Series C
- Piper Sandler (https://capitalatlas.ai/funds/piper-sandler) — Series C
- Howard Hughes Medical Institute — Series C
- AvTech Ventures (https://capitalatlas.ai/funds/avtech-ventures) — Series C